keyword
https://read.qxmd.com/read/38646392/approach-to-abnormal-liver-biochemistries-in-the-primary-care-setting
#21
REVIEW
Rajesh R, Aditya Sangameshwar, Yi Yuan Tan, Kevin Teh Kim Jun, Tat Yean Tham, Mark Cheah Chang Chuen
Liver biochemistries are commonly ordered in the primary care setting, and they may return abnormal even in an asymptomatic patient. Primary care physicians need to have a systematic way of interpreting any derangement in these tests so that further investigations, referrals, and management can be arranged appropriately. This review dwells into patterns of liver biochemistry derangement, common aetiologies to consider, history and examinations that are required, initial investigations to order, and when to refer urgently to the emergency department...
March 2024: Curēus
https://read.qxmd.com/read/38646227/a-retrospective-study-evaluating-guideline-adherence-of-neonatal-parenteral-nutrition-in-a-belgian-neonatal-intensive-care-unit
#22
JOURNAL ARTICLE
Truc-Doan Nguyen, Garmt Meers, Pieter-Jan Cortoos, Stephane Steurbaut, Filip Cools
Introduction Clinical nutrition for preterm and critically ill neonates remains a challenge. Preterms are often hemodynamically and metabolically compromised, which limits infusion volumes of nutrients and hinders achieving recommended nutrient intakes. While guidelines provide recommended ranges for parenteral nutrition (PN) intakes, they generally recommend enteral nutrition as soon as possible. Thus, in clinical practice, gradually increasing EN intakes complicates assessments of PN guideline adherence. Via a pragmatic approach, we assessed adherence to PN recommendations for macronutrients and energy as stated in the 2018 guidelines of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)...
March 2024: Curēus
https://read.qxmd.com/read/38644669/gastrointestinal-small-intestinal-angioedema-induced-by-angiotensin-converting-enzyme-inhibitors
#23
REVIEW
G Zeng, Y Li
No abstract text is available yet for this article.
April 21, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38643935/rome-iii-criteria-capture-higher-irritable-bowel-syndrome-snp-heritability-and-highlight-a-novel-genetic-link-with-cardiovascular-traits
#24
JOURNAL ARTICLE
Leticia Camargo Tavares, Esteban Alexander Lopera-Maya, Ferdinando Bonfiglio, Tenghao Zheng, Trishla Sinha, Francine Zanchetta Marques, Alexandra Zhernakova, Serena Sanna, Mauro D'Amato
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) shows genetic predisposition, and large-scale genome-wide association studies (GWAS) are emerging, based on heterogeneous disease definitions. We aimed at investigating the genetic architecture of IBS defined according to gold-standard Rome Criteria. METHODS: We conducted GWAS meta-analyses of Rome III IBS and its subtypes in 24,735 IBS cases and 77,149 asymptomatic controls from two independent European cohorts (UK Biobank and Lifelines)...
April 18, 2024: Cellular and Molecular Gastroenterology and Hepatology
https://read.qxmd.com/read/38643783/managing-irritable-bowel-syndrome-balancing-diet-and-pharmacotherapy
#25
JOURNAL ARTICLE
Uday C Ghoshal, Uzma Mustafa, Mahesh K Goenka
No abstract text is available yet for this article.
April 18, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38643782/a-low-fodmap-diet-plus-traditional-dietary-advice-versus-a-low-carbohydrate-diet-versus-pharmacological-treatment-in-irritable-bowel-syndrome-carbis-a-single-centre-single-blind-randomised-controlled-trial
#26
JOURNAL ARTICLE
Sanna Nybacka, Hans Törnblom, Axel Josefsson, Johann P Hreinsson, Lena Böhn, Åsa Frändemark, Cecilia Weznaver, Stine Störsrud, Magnus Simrén
BACKGROUND: Dietary advice and medical treatments are recommended to patients with irritable bowel syndrome (IBS). Studies have not yet compared the efficacy of dietary treatment with pharmacological treatment targeting the predominant IBS symptom. We therefore aimed to compare the effects of two restrictive dietary treatment options versus optimised medical treatment in people with IBS. METHODS: This single-centre, single-blind, randomised controlled trial was conducted in a specialised outpatient clinic at the Sahlgrenska University Hospital, Gothenburg, Sweden...
April 18, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38642564/pathophysiology-and-therapeutic-options-for-cirrhotic-portal-hypertension
#27
REVIEW
Sergi Guixé-Muntet, Sergio Quesada-Vázquez, Jordi Gracia-Sancho
Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome. Existing knowledge indicates that the profibrogenic phenotype acquired by sinusoidal cells is the initial factor leading to increased hepatic vascular tone and fibrosis, which cause increased vascular resistance and portal hypertension...
April 17, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38642343/recam-j-2023-validation-and-development-of-the-japanese-version-of-recam-for-the-diagnosis-of-drug-induced-liver-injury
#28
JOURNAL ARTICLE
Atsushi Tanaka, Keiji Tsuji, Yasuyuki Komiyama, Kota Tsuruya, Keisuke Kakisaka, Akemi Tsutsui, Keiko Ichimoto, Masayuki Ueno, Yuki Okazaki, Hiroteru Kamimura, Atsushi Takai, Noriyo Yamashiki, Takanori Ito, Masaaki Watanabe, Masanori Abe, Ken-Ichi Harada, Tatehiro Kagawa
AIM: The diagnosis of drug-induced liver injury (DILI) is challenging. We modified the revised electronic version of the Roussel Uclaf Causality Assessment Method (RUCAM) for the diagnosis of DILI (RECAM), the scoring system developed in US and Spanish cohorts in 2022, and developed RECAM-J 2023 to align with the clinical practice in Japan. In the current study, we introduce RECAM-J 2023 and verify its performance in the context of Japanese patients with DILI. METHODS: After translation of RECAM into Japanese, modifications were made to develop RECAM-J 2023 without any alteration to the scores...
April 20, 2024: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38642000/endurance-exercise-associated-with-a-fructooligosaccharide-diet-modulates-gut-microbiota-and-increases-colon-absorptive-area
#29
JOURNAL ARTICLE
Filipe Moura, Caroline Romeiro, Bernardo Petriz, Nathalia Cavichiolli, Jeeser A Almeida, Alinne Castro, Octavio L Franco
BACKGROUND AND AIM: Fructooligosaccharide (FOS) supplementation can stimulate beneficial intestinal bacteria growth, but little is known about its influence on training performance. Therefore, this study analyzed FOS and exercise effects on gut microbiota and intestinal morphology of C57Bl/6 mice. METHODS: Forty male mice were divided into four groups: standard diet-sedentary (SDS), standard diet-exercised (SDE), FOS supplemented (7.5% FOS)-sedentary (FDS), and FOS supplemented-exercised (FDE), n = 10 each group...
April 20, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38641971/antacids-and-reflux-esophagitis-as-a-risk-factor-for-gastric-neoplasm-of-fundic-gland-type-a-retrospective-matched-case-control-study
#30
JOURNAL ARTICLE
Junnosuke Hayasaka, Shu Hoteya, Yutaka Takazawa, Daisuke Kikuchi, Akihiro Araki
BACKGROUND AND AIM: Since the first report of gastric adenocarcinoma of the fundic-gland type in 2010, the clinicopathological characteristics of gastric neoplasm of the fundic-gland type (GNFG) have become clearer; however, their risk factors remain unclear. This exploratory study aimed to identify the risk factors for GNFG. METHODS: We conducted a single-center, retrospective, matched case-control study using medical information recorded at our health management center from January 2014 to July 2023...
April 20, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38641251/redefining-challenging-liver-thermal-ablation-cases-present-realities-future-prospects
#31
EDITORIAL
Tom Boeken
No abstract text is available yet for this article.
April 17, 2024: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/38641250/ppar%C3%AE-%C3%AE-as-a-promising-molecular-drug-target-for-liver-diseases-a-focused-review
#32
REVIEW
Xin Meng, Lin Wang, Yan-Chao Du, Dong Cheng, Tao Zeng
Various liver diseases pose great threats to humans. Although the etiologies of these liver diseases are quite diverse, they share similar pathologic phenotypes and molecular mechanisms such as oxidative stress, lipid and glucose metabolism disturbance, hepatic Kupffer cell (KC) proinflammatory polarization and inflammation, insulin resistance, and hepatic stellate cell (HSC) activation and proliferation. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is expressed in various types of liver cells with relatively higher expression in KCs and HSCs...
April 17, 2024: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/38641249/the-prognostic-nutritional-index-as-a-predictor-of-efficacy-and-early-recurrence-for-adjuvant-transarterial-chemoembolization-in-hepatocellular-carcinoma
#33
JOURNAL ARTICLE
Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai
BACKGROUND AND AIMS: Postoperative adjuvant transcatheter arterial chemoembolization (TACE) can prevent recurrence of hepatocellular carcinoma (HCC) in certain patients. This study aimed to identify the potential beneficiaries of adjuvant TACE. METHODS: 477 patients who underwent curative resection for HCC were enrolled in this retrospectively cohort study. The trajectory of the prognostic nutritional index (PNI) during the perioperative period was fitted using a latent-class growth mixed model...
April 17, 2024: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/38641219/en-bloc-endoscopic-submucosal-dissection-of-a-large-laterally-spreading-tumor-involving-the-papilla
#34
JOURNAL ARTICLE
Shuhan Yu, Yonggang Ding, Qide Zhang
No abstract text is available yet for this article.
April 17, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38641207/lactobacillus-rhamnosus-gg-stimulates-dietary-tryptophan-dependent-production-of-barrier-protecting-methylnicotinamide
#35
JOURNAL ARTICLE
Panan Suntornsaratoon, Jayson M Antonio, Juan Flores, Ravij Upadhyay, John Veltri, Sheila Bandyopadhyay, Rhema Dadala, Michael Kim, Yue Liu, Iyshwarya Balasubramanian, Jerrold R Turner, Xiaoyang Su, Wei Vivian Li, Nan Gao, Ronaldo P Ferraris
BACKGROUND & AIMS: Lacticaseibacillus rhamnosus GG (LGG) is the world's most consumed probiotic but its mechanism of action on intestinal permeability and differentiation along with its interactions with an essential source of signaling metabolites, dietary tryptophan, are unclear. METHODS: Untargeted metabolomic and transcriptomic analyses were performed in LGG mono-colonized germ-free (GF) mice fed tryptophan (trp)-free or -sufficient diets. LGG-derived metabolites were profiled in vitro under anaerobic and aerobic conditions...
April 17, 2024: Cellular and Molecular Gastroenterology and Hepatology
https://read.qxmd.com/read/38640938/pants-extension-study-how-best-to-use-anti-tnf-drugs-in-crohn-s-disease
#36
JOURNAL ARTICLE
Gareth C Parkes, Charlotte R H Hedin
No abstract text is available yet for this article.
April 16, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38640937/mechanisms-and-management-of-loss-of-response-to-anti-tnf-therapy-for-patients-with-crohn-s-disease-3-year-data-from-the-prospective-multicentre-pants-cohort-study
#37
JOURNAL ARTICLE
Neil Chanchlani, Simeng Lin, Claire Bewshea, Benjamin Hamilton, Amanda Thomas, Rebecca Smith, Christopher Roberts, Maria Bishara, Rachel Nice, Charlie W Lees, Shaji Sebastian, Peter M Irving, Richard K Russell, Timothy J McDonald, James R Goodhand, Tariq Ahmad, Nicholas A Kennedy
BACKGROUND: We sought to report the effectiveness of infliximab and adalimumab over the first 3 years of treatment and to define the factors that predict anti-TNF treatment failure and the strategies that prevent or mitigate loss of response. METHODS: Personalised Anti-TNF therapy in Crohn's disease (PANTS) is a UK-wide, multicentre, prospective observational cohort study reporting the rates of effectiveness of infliximab and adalimumab in anti-TNF-naive patients with active luminal Crohn's disease aged 6 years and older...
April 16, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38640041/alcohol-associated-liver-disease-global-epidemiology
#38
JOURNAL ARTICLE
Fredrik Åberg, Z Gordon Jiang, Helena Cortez-Pinto, Ville Männistö
Alcohol-associated liver disease (ALD), as highlighted in this narrative review, is a major public health concern, increasingly impacting global disease burden and premature mortality. In 2019, ALD accounted for the loss of 11 million life-years worldwide. The rising number of deaths and disability-adjusted life years attributed to ALD, particularly pronounced in America, are alarming. Projections suggest that the economic impact of ALD, as seen in the United States, could potentially double by 2040. ALD is increasingly prevalent among younger adults and has become the leading cause for liver transplantation in both America and Europe...
April 19, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38640021/clonal-hematopoiesis-of-indeterminate-potential-and-risk-of-hepatocellular-carcinoma-new-kids-on-the-block
#39
JOURNAL ARTICLE
Yi-Te Lee, Hsian-Rong Tseng, Ju Dong Yang
No abstract text is available yet for this article.
April 19, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38638382/liver-transplantation-reverses-hepatic-myelopathy-in-the-decompensated-phase-of-cirrhosis-case-report-and-literature-review
#40
Jiajun Li, Sile Wan, Fukai Wen, Qingyu Li, Yifeng Cui, Zhaoyang Lu, Han Lin
Hepatic myelopathy (HM) is a rare neurological complication in the end stage of many liver diseases and is characterized by bilateral spastic paraparesis without sensory and sphincter dysfunction. It occurs owing to metabolic disorders and central nervous system dysfunction associated with cirrhosis. Without timely and effective clinical intervention, the prognosis of these patients is devastating. Although liver transplantation (LT) is an effective treatment for HM, the prognosis of these patients remains unsatisfactory...
April 28, 2024: Journal of Clinical and Translational Hepatology
keyword
keyword
100093
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.